Sandoz Pty Ltd have advised that all batches of Metronidazole Sandoz IV 500mg/100ml Injection Solution Bag are being recalled. This is due to a potential lack of assurance sterility.
For more details please read the following recall statement. For APHS pharmacy purposes only, please use the attached return authority.

Due to reports of anaphylaxis potentially associated with batch AH5067, there is an urgent recall on Cefazolin Sandoz 1g 10 Vials. Please see the recall notice for further details.

After consultation with the Therapeutic Goods Administration, AstraZeneca is conducting a sponsor-initiated recall of two batches of Xylocaine 4% Topical Solution 30mL bottle packs of 1, batch numbers 1294883 and 1299209. The recall is being undertaken because AstraZeneca has determined that the fill volume in some bottles is slightly higher than the in process specification [...]

Influenza doesn’t recognise State borders, so we are delighted to announce that APHS through its Home Therapeutics brand recently acquired the HealthVax business under which our vaccination business will expand nationally. HealthVax, an established Victorian brand, gives us a strong base from which to market our vaccination services to the Southern States.
The first early success [...]

Welcome to the new APHS website and thank you for visiting us. We’ve designed the site to be more interactive and tried to make it easier for you to find out the information you need.
We look forward to getting to know you.

The APHS Advisory Board held its inaugural meeting over the Australian Pharmacy Professional Conference (APP) weekend on the Gold Coast in March. The new Board which will oversee the long term strategy and direction of APHS and provide Governance began with an overview of the business and coming challenges and opportunities.